SS

Sangeeta Srivastva

Active Director Director DIN 01834695
DIN 01834695 First appointment Apr 2004 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Apr 2004
Shareholding value •••• Premium profile

About Sangeeta Srivastva

Data last updated:

Sangeeta Srivastva is a Director at Ramans Healthcare And Diagnostics Private Limited (since 2017), Director at Dev Institute Of Nuclear Medicine Private Limited (since 2004) and Director at Asrb Medical Services Private Limited (since 2020), and holds 1 more current directorship. The companies operate in Healthcare and Engineering. The 3 current companies with reported revenue have a combined latest revenue of ₹14.37 Cr; the largest is Ramans Healthcare And Diagnostics Private Limited at ₹8.56 Cr (FY 2024). Earlier, Sangeeta Srivastva was a Director at Raman Imaging And Diagnostic Private Limited (2020–2021).

DIN 01834695
Primary Designation Director
Industry Healthcare
First Appointment 08 Apr 2004
Oldest Company Age 22 yrs
Largest company Ramans Healthcare And Diagnostics Private Limited · ₹8.56 Cr (FY 2024)
Combined revenue ₹14.37 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Oct 20172017₹8.56 Cr (FY 2024)Active
Director08 Apr 20042004₹5.79 Cr (FY 2021)Active
Director13 May 20202018₹1.9 Lakh (FY 2025)Active
Designated Partner08 Mar 20192019Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Dec 20202020₹7.03 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dev Institute Of Nuclear Medicine Private Limited
Asrb Medical Services Private Limited
Ramans Healthcare And Diagnostics Private Limited
Nuclear Imaging And Therapy Llp
Premium access

Shareholding and investment profile for Sangeeta Srivastva

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sangeeta Srivastva

Sangeeta Srivastva currently holds 4 directorships: Ramans Healthcare And Diagnostics Private Limited (Director, since 05 Oct 2017, revenue ₹8.56 Cr (FY 2024)); Dev Institute Of Nuclear Medicine Private Limited (Director, since 08 Apr 2004, revenue ₹5.79 Cr (FY 2021)); Asrb Medical Services Private Limited (Director, since 13 May 2020, revenue ₹1.9 Lakh (FY 2025)); Nuclear Imaging And Therapy Llp (Designated Partner, since 08 Mar 2019).

Sangeeta Srivastva was first appointed on 08 Apr 2004 as Director at Dev Institute Of Nuclear Medicine Private Limited. The most recent appointment on record is 16 Dec 2020 at Raman Imaging And Diagnostic Private Limited.

The 3 current companies of Sangeeta Srivastva that report revenue have a combined latest revenue of ₹14.37 Cr: Ramans Healthcare And Diagnostics Private Limited ₹8.56 Cr (FY 2024); Dev Institute Of Nuclear Medicine Private Limited ₹5.79 Cr (FY 2021); Asrb Medical Services Private Limited ₹1.9 Lakh (FY 2025).

Sangeeta Srivastva held 1 earlier board appointment: Raman Imaging And Diagnostic Private Limited (Director, 16 Dec 2020 to 24 Nov 2021).

The current boards of Sangeeta Srivastva's companies include Bipin Kumar Srivastava (Ramans Healthcare And Diagnostics Private Limited), Girish Kumar Srivastava (Dev Institute Of Nuclear Medicine Private Limited), Ravi Shankar Kumar (Dev Institute Of Nuclear Medicine Private Limited), Vihag Raman (Dev Institute Of Nuclear Medicine Private Limited), Riya Kumar (Asrb Medical Services Private Limited), Ram Narayan Singh (Nuclear Imaging And Therapy Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available